Ally Bridge Group (Ny) LLC Top Holdings and 13F Report (2024) → Kiss of death from Joe Biden (From Porter & Company) (Ad) About Ally Bridge Group (Ny) LLCInvestment ActivityAlly Bridge Group (Ny) LLC has $179.89 million in total holdings as of March 31, 2024.Ally Bridge Group (Ny) LLC owns shares of 22 different stocks, but just 14 companies or ETFs make up 80% of its holdings.Approximately 64.52% of the portfolio was purchased this quarter.About 64.10% of the portfolio was sold this quarter.This quarter, Ally Bridge Group (Ny) LLC has purchased 22 new stocks and bought additional shares in 4 stocks.Ally Bridge Group (Ny) LLC sold shares of 4 stocks and completely divested from 13 stocks this quarter.Largest Holdings Blueprint Medicines $15,267,717Soleno Therapeutics $14,401,601CG ONCOLOGY INC $14,064,594Xenon Pharmaceuticals $13,318,335Verona Pharma $11,854,114 Largest New Holdings this Quarter Blueprint Medicines $15,267,717 HoldingCG ONCOLOGY INC $14,064,594 HoldingVerona Pharma $11,854,114 HoldingMind Medicine (MindMed) $9,413,649 HoldingJASPER THERAPEUTICS INC $8,512,726 Holding Largest Purchases this Quarter Blueprint Medicines 160,950 shares (about $15.27M)CG ONCOLOGY INC 320,378 shares (about $14.06M)Verona Pharma 736,738 shares (about $11.85M)Mind Medicine (MindMed) 1,001,452 shares (about $9.41M)JASPER THERAPEUTICS INC 289,943 shares (about $8.51M) Largest Sales this Quarter Olema Pharmaceuticals 100,000 shares (about $1.13M)Merus 18,995 shares (about $855.34K)Geron 211,142 shares (about $696.77K)ProMIS Neurosciences 7,092 shares (about $13.55K) Sector Allocation Over TimeMap of 500 Largest Holdings ofAlly Bridge Group (Ny) LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorBPMCBlueprint Medicines$15,267,717$15,267,717 ▲New Holding160,9508.5%MedicalSLNOSoleno Therapeutics$14,401,601$1,135,741 ▲8.6%336,4868.0%MedicalCG ONCOLOGY INC$14,064,594$14,064,594 ▲New Holding320,3787.8%COMXENEXenon Pharmaceuticals$13,318,335$2,901,914 ▲27.9%309,3697.4%MedicalVRNAVerona Pharma$11,854,114$11,854,114 ▲New Holding736,7386.6%MedicalMRUSMerus$11,524,438$855,345 ▼-6.9%255,9286.4%MedicalPRAXIS PRECISION MEDICINES I$9,731,836$5,434,563 ▲126.5%159,4865.4%COMMNMDMind Medicine (MindMed)$9,413,649$9,413,649 ▲New Holding1,001,4525.2%MedicalAVDLAvadel Pharmaceuticals$9,239,438$3,378,000 ▲57.6%547,0365.1%MedicalGERNGeron$9,109,640$696,769 ▼-7.1%2,760,4975.1%MedicalJASPER THERAPEUTICS INC$8,512,726$8,512,726 ▲New Holding289,9434.7%COM NEWKURAKura Oncology$7,786,389$7,786,389 ▲New Holding365,0444.3%MedicalINSMInsmed$6,782,500$6,782,500 ▲New Holding250,0003.8%MedicalDIANTHUS THERAPEUTICS INC$6,509,040$6,509,040 ▲New Holding216,9683.6%COMOLMAOlema Pharmaceuticals$6,328,276$1,132,000 ▼-15.2%559,0353.5%MedicalLYRALyra Therapeutics$6,243,269$6,243,269 ▲New Holding1,003,7413.5%MedicalLBPHLongboard Pharmaceuticals$5,844,074$5,844,074 ▲New Holding270,5593.2%MedicalRAPTRAPT Therapeutics$3,771,600$3,771,600 ▲New Holding420,0002.1%MedicalMRSNMersana Therapeutics$3,590,438$3,590,438 ▲New Holding801,4372.0%MedicalMRNSMarinus Pharmaceuticals$3,568,748$3,568,748 ▲New Holding394,7732.0%MedicalPMNProMIS Neurosciences$2,023,802$13,546 ▼-0.7%1,059,5821.1%MedicalCNTXContext Therapeutics$1,001,8120.0%725,9510.6%MedicalJSPRJasper Therapeutics$0$28,871,522 ▼-100.0%00.0%MedicalARGXargenx$0$13,315,050 ▼-100.0%00.0%MedicalCBAYCymaBay Therapeutics$0$11,572,336 ▼-100.0%00.0%MedicalITCIIntra-Cellular Therapies$0$10,123,344 ▼-100.0%00.0%MedicalAPLSApellis Pharmaceuticals$0$8,979,000 ▼-100.0%00.0%MedicalMLTXMoonLake Immunotherapeutics$0$8,664,697 ▼-100.0%00.0%MedicalAXSMAxsome Therapeutics$0$8,027,607 ▼-100.0%00.0%MedicalALPNAlpine Immune Sciences$0$6,809,585 ▼-100.0%00.0%MedicalAMBRX BIOPHARMA INC$0$5,487,854 ▼-100.0%00.0%COMHARPOON THERAPEUTICS INC$0$4,870,908 ▼-100.0%00.0%COM NEWAMLXAmylyx Pharmaceuticals$0$4,059,379 ▼-100.0%00.0%MedicalCMPXCompass Therapeutics$0$1,302,023 ▼-100.0%00.0%MedicalMEDAVAIL HOLDINGS INC$0$529,358 ▼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.